Penwest Pharmaceuticals Shareholders Approve Merger With Subsidiary of Endo Pharmaceuticals PR Newswire PATTERSON, N.Y., Nov. 4, 2010 PATTERSON...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 NOTICE OF EFFECTIVENESS Effective Date: November 01, 2010...
Endo Pharmaceuticals Reports Strong Third Quarter 2010 Financial Results; Reaffirms 2010 Financial Guidance and Provides Financial Guidance for...
As filed with the Securities and Exchange Commission on October 29, 2010 REGISTRATION NO. 333-152086 ...
As filed with the Securities and Exchange Commission on October 29, 2010 REGISTRATION NO. 333-150180 UNITED STATES SECURITIES AND EXCHANGE...
As filed with the Securities and Exchange Commission on October 29, 2010 REGISTRATION NO. 333-153697 UNITED STATES SECURITIES AND EXCHANGE...
OMB APPROVAL OMB Number: Expires: Estimated average burden Hours per response ...
Penwest Pharmaceuticals Announces Intention to Terminate NASDAQ Listing and Registration PR Newswire PATTERSON, N.Y., Oct. 15 PATTERSON, N.Y...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.